These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 9723264

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H, Asmundsson P, Clausen P, Dieperink H, Hansen JM, Heaf J, Jensen SB, Kornerup HJ, Madsen S, Pedersen EB, Poulsen JV, Rasmussen K.
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
    Papachristou F, Gakis D, Sotiriou I, Liatsis I, Takoudas D, Antoniadis A.
    Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
    [No Abstract] [Full Text] [Related]

  • 5. Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral.
    Serafinowicz A, Gaciong Z, Majchrzak J, Baczkowska T, Nowacka E, Gradowska L, Rowiński W, Lao M.
    Transplant Proc; 1997 Aug; 29(1-2):277-9. PubMed ID: 9122994
    [No Abstract] [Full Text] [Related]

  • 6. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR, Weiskittel P, Shah M, Peddi VR, Canafax D, Schroeder TJ.
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract] [Full Text] [Related]

  • 7. Conversion from Sandimmune to Neoral in patients with stable renal allograft function: UHKL experience.
    Goh BL, Jalil R, Koh SN, Chua CT, Tan SY.
    Transplant Proc; 1998 Nov; 30(7):3535-6. PubMed ID: 9838548
    [No Abstract] [Full Text] [Related]

  • 8. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M, Satta R, Branca GF, Pala PG, Serra G, Satta RP, Sorba G.
    Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
    De Palma MT, Giordano M, Colella V, Palumbo F, De Nicolo VE, Caringella DA.
    Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
    [No Abstract] [Full Text] [Related]

  • 11. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK, Ho YW, Tong KL, Chan WH, Chan A.
    Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract] [Full Text] [Related]

  • 12. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
    Taesch S, Niese D.
    Transpl Int; 1994 Jun; 7 Suppl 1():S263-6. PubMed ID: 11271220
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neoral pharmacokinetics in cynomolgus monkeys: relation to efficacy in renal allografting.
    Schuurman HJ, Hengy JC, Ringers J, Vonderscher J, Schuler W, Jonker M.
    Transplant Proc; 1996 Dec; 28(6):3142-4. PubMed ID: 8962218
    [No Abstract] [Full Text] [Related]

  • 18. The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
    Wilczek HE, Berglin E, Blohmé I, Bäckman L, Fehrman I, Källen R, Nyberg G, Säwe J, Wahlberg J.
    Transplant Proc; 1997 Dec; 29(1-2):280-3. PubMed ID: 9122995
    [No Abstract] [Full Text] [Related]

  • 19. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A, Pinto VM, Elberg A.
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract] [Full Text] [Related]

  • 20. Mass conversion from Sandimmun to Sandimmun Neoral: 1 1/2-year experience.
    Huraib S, al Khudair W, Selim H, Iqbal A, Quadri K, Abu Romeh S, Chaballout A.
    Transplant Proc; 1997 Nov; 29(7):2980-2. PubMed ID: 9365637
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.